Abstract
The bipyridine derivatives, amrinone and milrinone, are agents with positive inotropic and peripheral vasodilatory properties. They are the only orally effective positive inotropic agents except for digitalis glycosides. Therefore, they may be expected to play an important role in treatment of elderly patients with congestive heart failure and sinus rhythm in whom digitalis is often ineffective or not tolerated at therapeutic doses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amrinone
Evans DB, et al: In vitro and in vivo cardio-stimulant actions of amrinone and prenalterol [abstr]. Pharmacologist 22:287, 1980.
Alousi AA, et al: Cardiotonic activity of amrinone: Win 40680 (5-amino-3,4′-bipyridin-6(1H)-one). Circ Res 45:666, 1979.
Alousi A, et al: Comparative inotropic activity of amrinone in isolated human atria and cat atria and papillary muscle [abstr]. J Mol Cell Cardiol [Suppl 1] 11:2, 1979.
Benotti JR, et al: Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62:28, 1980.
Wynne J, et al: Oral amrinone in refractory congestive heart failure. Am J Cardiol 45:1245, 1980.
LeJemtel TH, et al: Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure. Am J Cardiol 45:123, 1980.
LeJemtel TH, et al: Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 59:1979.
Packer M, et al: Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure. Am J Cardiol 54:1025, 1984.
Dibianco R, et al: Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. J Am Coll Cardiol 4:855, 1984.
Gaide MS, et al: Characterization of the inotropic and biochemical properties of amrinone: a novel cardiotonic agent [abstr]. Am J Cardiol 45:412, 1980.
Kullberg MP, et al: Amrinone metabolism. Clin Pharmacol Ther 29:394, 1981.
Edelson J, et al: Dose proportionality of amrinone. Clin Pharmacol Ther 34:190, 1983.
Alousi AA, Dobreck HP: Amrinone. In: Scriabine A (ed) New drugs annual: cardiovascular drugs. Raven, New York, 1983.
Wilsmhurst PT, Webb-Peploe MM: Side effects of amrinone therapy. Br Heart J 49:447, 1983.
Milrinone
Bairn DS, et al: Evaluation of a new bipyridine inotropic agent—milrinone—in patients with severe congestive heart failure. N Engl J Med 309:748, 1983.
Maskin CS, et al: Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47209, in patients with severe congestive heart failure. Circulation 67:1065, 1983.
Benotti JR, et al: Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. Am J Cardiol 56:685, 1985.
Holmes JR, et al: Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias. Am Heart J 110:800, 1985.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Schneeweiss, A., Schettler, G. (1988). Bipyridine Derivatives. In: Cardiovascular Drug Therapy in the Elderly. Developments in Cardiovascular Medicine, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2063-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2063-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9225-8
Online ISBN: 978-1-4613-2063-0
eBook Packages: Springer Book Archive